Review of Commercialization process of biopharmaceuticals: Lessons for Iran's drug industry

Development of pharmaceutical industry in each country reflects its capabilities in the field of health care. Considering the progress of pharmaceutical industry and biotechnology in the same line and the role of biopharmaceuticals in the treatment of especial diseases in the societies, investigation of the commercialization process and determination of critical factors which accelerating the entrance the medicines to the market, is very crucial. The aim of this paper is to investigate different aspects of the drug commercialization process. The methodology of this research was based on literature review and deduction of related scientific papers and reports. The result of the research showed that one of the key factors in success of Iranian pharmaceutical companies is familiarity with various methods of funding appropriate to the stage of new medicine development. Likewise, the need for strategic alliances between large pharmaceutical companies and domestic startup biopharmaceutical companies with their foreign counterparts should be considered. Since there is not detailed information about innovations and new products developed by domestic companies, finally, proposed that the Food and Drug Administration of Iran or the Ministry of Health and Medical Education conduct an innovation survey in the pharmaceutical industry of the country.